CME Group Inc. $CME Shares Sold by Xponance Inc.

Xponance Inc. lessened its stake in CME Group Inc. (NASDAQ:CME) by 6.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 53,317 shares of the financial services provider’s stock after selling 3,902 shares during the quarter. Xponance Inc.’s holdings in CME Group were worth $14,406,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Jessup Wealth Management Inc boosted its holdings in CME Group by 0.5% in the second quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock valued at $2,197,000 after acquiring an additional 36 shares during the last quarter. First Horizon Advisors Inc. increased its stake in CME Group by 0.7% during the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after acquiring an additional 36 shares during the last quarter. MBM Wealth Consultants LLC raised its holdings in shares of CME Group by 2.7% in the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after purchasing an additional 37 shares during the period. West Family Investments Inc. raised its holdings in shares of CME Group by 1.2% in the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the period. Finally, Atlatl Advisers LLC lifted its stake in shares of CME Group by 1.8% in the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after purchasing an additional 38 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CME has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Jefferies Financial Group cut their price objective on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. UBS Group reaffirmed a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research report on Friday, February 6th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research report on Thursday, February 5th. Finally, Royal Bank Of Canada boosted their target price on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 5th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $299.53.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

Insider Transactions at CME Group

In other CME Group news, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. This trade represents a 21.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the transaction, the director owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. This represents a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,248 shares of company stock worth $8,355,450 over the last 90 days. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.0%

Shares of NASDAQ:CME opened at $319.50 on Friday. The company’s fifty day moving average is $287.63 and its two-hundred day moving average is $275.97. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. CME Group Inc. has a 1-year low of $248.53 and a 1-year high of $322.57. The stock has a market capitalization of $115.21 billion, a price-to-earnings ratio of 28.63, a price-to-earnings-growth ratio of 3.70 and a beta of 0.27.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company posted $2.52 earnings per share. CME Group’s revenue was up 8.1% on a year-over-year basis. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.6%. CME Group’s dividend payout ratio is 44.80%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.